Prednisone Withdrawn Phase 4 Trials for Transplantation, Kidney / Renal Transplant Recipient Patients / Cardiovascular Disease (CVD) / Cardiovascular Outcomes Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02058875Cardiovascular Risk Following Conversion to Full Dose Myfortic® and Neoral® Two-hour Post Level Monitoring